One patient whose primary melanoma tumor was reported to be wild‐type for BRAF (COBAS Real‐Time Polymerase Chain Reaction performed in a CLIA‐approved Molecular Diagnostics Laboratory) was found to have a circulating BRAF V600E mutation. This evidence concerns the gene BRAF and neoplasm.